Silexion Therapeutics (SLXN) Liabilities and Shareholders Equity (2023 - 2026)
Silexion Therapeutics' Liabilities and Shareholders Equity came in at $4.25 million for Q2 2026, down 26.8% from $5.8 million a year earlier and down 7.7% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Silexion Therapeutics' Liabilities and Shareholders Equity was $7.22 million, up 152.0% from FY2024.
- Going back by year, Liabilities and Shareholders Equity was $2.86 million in FY2024 (-45.5%) and $5.26 million in FY2023.
- The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2024.
- Year-over-year, Liabilities and Shareholders Equity increased in four of the last seven quarters, with growth averaging 84.8%.
- Business Quant data shows SLXN's Liabilities and Shareholders Equity at $4.6 million (Q1 2026), $7.22 million (Q4 2025) and $11.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Silexion Therapeutics | 192,458.84 | -19.68 Mn | - | 4.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | 11.61 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 5.26 Mn |
API Access
Silexion Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();